Evidence map›Paper›PMID 36568665›Full record

ArticleHeliyon2022

Evaluation of diagnostic parameters in detecting prediabetes in a cohort of Syrian healthcare providers and staff: correlations with risk factors.

Lina Albitar

Open access · goldAbstract read
In one paragraph

Article in Heliyon, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 74% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 0 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Lina AlbitarDepartment of Pharmaceutics, Faculty of Pharmacy, Arab International University, Damascus, Syria.
Arab International University · SY

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Diabetes is spreading more rapidly in lower-middle-income countries like Syria. Early prevention programs are crucial and achievable through identification, treatment, and revision of prediabetes. Evaluation of hyperglycemia diagnostic parameters (FPG, OGTT, HbA1c) in detecting prediabetes was executed through three phases of screening asymptomatic adults and applying the parameters sequentially. Relationships with risk factors from the American Diabetes Association (ADA) were assessed. Correlations amongst lipid profile (total cholesterol, LDL, HDL, and TG) and hyperglycemic parameters were additionally explored. Participants (212) were mainly males (60.4%), married (61.5%), healthcare providers (28.8%), and had first-degree relatives with diabetes (32%). 10.6% had hypertension, 6.8% had dyslipidemia, and 10.7% of the female participants had PCO. Following the ADA criteria, 18% and 1.9% of the participants were diagnosed with prediabetes and diabetes, respectively. The cohort of participants with prediabetes and diabetes had higher percentage of first-degree relative with diabetes (70%), obesity (55%), hypertension (25%), dyslipidemia (15%), and PCO in females (20%). They were mainly professors (40%) and healthcare providers (25%). Interrelations amongst the hyperglycemic parameters were revealed, also with lipids and risk factors mainly age, BMI, familial diabetes, dyslipidemia, and hypertension. Reports on prediabetes are scarce in Syria. This study, one of a few on the topic, investigated the hyperglycemic parameters in detecting prediabetes and revealed the prevalence and the correlation with risk factors and lipids. It adds substantial information to our understanding of the intertwined associations of the studied variables.

Indexed as

CorrelationDiabetes mellitusHyperglycemia screening assessmentPrediabetesPreventionSyria

Identifiers

PMID36568665
PMCPMC9768301
OpenAlexW4311147455

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.